Table 1. Mechanism of HCV inhibition by catechins and their derivatives.
Category | Test compound | Propagation and target cells | Genotype | Mode of action | Molecular target of inhibition | Reference |
---|---|---|---|---|---|---|
Catechin and derivatives | EGCG | HCVcc (JFH1) and Huh7.5.1 | 2a | Suppression of both the HCV entry and RNA replication steps | ND | [16] |
EGCG, 7,8-benzoflavone | HCVcc (JFH1) and Huh7.5.1 | 2a, 1b | Early step (EGCG) and later stage (7,8-benzoflavone) | ND | [17] | |
63 Synthetic derivatives | Huh5.2 | - | In vitro inhibitory effect of catechin derivatives (linear and branched alkyl-esters, amides of gallic acid and other (mono-, di-, and tri-) hydroxy benzoyl derivatives) | ND | [18] | |
Mechanistic studies | EGCG | HCVcc, HCVpp and Huh-7.5 | 1a, 1b, 2a | Inhibition of virion attachment | E1/E2 | [22] |
EGCG | HCVcc, HCVpp and Huh-7 | 1a, 1b, 2a, 2b, 3a, 4, 5, 6 | EGCG possesses antiviral activity and impairs cellular lipid metabolism | E1/E2 | [23] | |
EGCG, delphinidin | HCVcc, HCVpp and Huh-7 | 2a | E1, E2 interaction mediated deformation of viral membrane | E1/E2 | [24] | |
EGCG | HCVcc (JFH1), Huh-7.5 | 2a | Competition with heparan sulfate for binding of HCV | Heparan sulfate | [25] | |
Alternative approaches | EGCG | HCVcc (JFH1), Huh-7 | 2a | Regulation of mir-194 and CD81 expression levels | miR-194, CD81 | [33] |
SHXT | HCVcc (JFH1), Huh-7 | 2a | Modulation of the activation of NF-κB and COX-2 | COX-2 | [34] | |
In vitro studies | EGCG | In vitro | - | QDs-RNA oligonucleotide | NS5B | [38] |
EGCG | In silico | - | Binding Interaction of HCV NS3 helicase active pocket | GT3a NS3 helicase | [39] |
HCV, hepatitis C virus; EGCG, (−)-epigallocatechin 3-gallate; HCVcc, cell-culture-derived HCV; ND, not determined; HCVpp, HCV pseudoparticles; SHXT, San-Huang-Xie-Xin-Tang; NF-κB, nuclear factor κB; COX-2, cyclooxygenase-2; QD, quantum dots.